Differential regulation of eosinophil adhesion under conditions of flow in vivo

Annals of the New York Academy of Sciences

Volumn 796, Issue , 1996, Pages 218-225

  Sriramarao, P ^a   Broide, David H ^b  

^a La Jolla Institute for Experimental Medicine   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CELL RECEPTOR; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 5; L SELECTIN; RANTES; THROMBOCYTE ACTIVATING FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ALLERGIC DISEASE; CELL ADHESION; CELL FUNCTION; CONFERENCE PAPER; ENDOTHELIUM CELL; EOSINOPHIL; HUMAN; INFLAMMATION; NEUTROPHIL; NONHUMAN; RABBIT; SHEAR STRESS; VASCULAR ENDOTHELIUM;

ORYCTOLAGUS CUNICULUS;

EID: 0029812190     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb32584.x     Document Type: Conference Paper

References (49)

1. DOBRINA, A., R. MENEGAZZI, T. M. CARLOS, E. NARDON, T. ZACCHI, J. M. HARLAN & P. PATRICIA. 1991. Mechanisms of eosinophil adherence to cultured vascular endothelial cells. Eosinophils bind to cytokine-induced ligand vascular cell adhesion molecule-1 via the very late activation antigen-4 integrin receptor. J. Clin. Invest. 88: 20-26.
2. SCHLEIMER, R. P., S. A. STERBINSKY, J. KAISER, C. A. BICKEL, D. A. KLUNK, K. TOMIOKA, W. NEWMAN, F. E. LUSCINSKAS, M. A. GIMBRONE, B. W. MCINTYRE & B. S. BOCHNER. 1992. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J. Immunol. 148: 1086-1092.
3. EBISAWA, M., B. S. BOCHNER, S. N. GEORAS & R. P. SCHLEIMER. 1992. Eosinophil transendothelial migration induced by cytokines. I Role of endothelial and eosinophil adhesion molecules in IL-1β-induced transendothelial migration. J. Immunol. 49: 4021-4028.
4. KNOL, E. F., F. TACKEY, T. F. TEDDER, D. A. KLUNK, C. A. BICKEL, S. A. STERBINSKY & B. S. BOCHNER. 1994. Comparison of human eosinophil and neutrophil adhesion to endothelial cells under nonstatic conditions. J. Immunol. 153: 2161-2167.
5. SRIRAMARAO, P., U. H. VON ANDRIAN, E. C. BUTCHER, M. A. BOURDON & D. H. BROIDE. 1994. L-selectin and very late antigen-4 integrin promote eosinophil rolling at physiological shear rates in vivo. J. Immunol. 153: 4238-4246.
6. BOCHNER, B. S., F. W. LUSCINSKAS, M. A. GIMBRONE, W. NEWMAN, W. A. STERBINSKY, C. DERSE-ANTHONY, D. KLUNK & R. P. SCHLEIMER. 1991. Adhesion of human basophils, eosinophils and neutrophils to IL-1 activated human vascular endothelial cells; Contributions of endothelial cell adhesion molecules. J. Exp. Med. 173: 1553-1556.
7. WELLER, P. F., T. H. RAND, S. E. GOELZ, G. CHI-ROSSO & R. R. LOBB. 1991. Human eosinophil adherence to vascular endothelium mediated by binding to vascular cell adhesion molecule 1 and endothelial leukocyte adhesion molecule 1. Proc. Natl. Acad. Sci. U.S.A. 88: 7430-7433.
8. SYMON, F. A., G. M. WALSH, S. R. WATSSON & A. J. WARDLAW. 1994. Eosinophil adhesion to nasal polyp endothelium is P-selectin dependent. J. Exp. Med. 180: 371-376.
9. EBISAWA, M., M. C. LIU, T. YAMADA, M. KATO, L. M. LICHTENSTEIN, B. S. BOCHNER & R. P. SCHLEIMER. 1994. Eosinophil transendothelial migration induced by cytokines. II. Potentiation of eosinophil transendothelial migration by eosinophil active cytokines. J. Immunol. 152: 4590-4596.
10. RESNICK, M. B. & P. F. WELLER. 1993. Mechanisms of eosinophil recruitment. Am. J. Respir. Cell Mol. Biol. 8: 349-355.
11. MOSER, R., J. FEHR & P. L. BRUIJNZEEL. 1992. Migration of primed human eosinophils across cytokine-activated endothelial cell monolayers. Blood 79: 2937-2945.
12. EBISAWA, M., Y. YAMADA, C. BICKEL, D. KLUNK & R. P. SCHLEIMER. 1994. Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES. J. Immunol. 153: 2153-2160.
13. HORIE, S. & H. KITA. 1994. CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human granulocyte-macrophage colony stimulating factor and platelet activating factor. J. Immunol. 152: 5457-5467.
14. WARRINGA, R. A., L. KOENDERMAN, P. T. KOK, J. KREUKNIET & P. L. BRUIJNZEEL. 1991. Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony stimulating factor and interleukin-3. Blood 77: 2694-2700.
15. WALSH, G. M., A. HARTNELL, A. J. WARDLAW, K. KURIHARA, C. J. SANDERSON & A. B. KAY. 1990. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/CD18)-dependent manner. Immunology 71: 258-265.
16. BUTCHER, E. C. 1991. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell 67: 1033-1036.
17. SPRINGER, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multi-step paradigm. Cell 76: 301-314.
18. VON ANDRIAN, U. H., P. HANSELL, J. D. CHAMBERS, E. M. BERGER, I. TORRES FILHO, E. C. BUTCHER & K.-E. ARFORS. 1992. L-selectin function is required for β2 integrin-mediated neutrophil adhesion at physiological shear rates in vivo. Am. J. Physiol. 263(32): H1034-H1044.
19. BEVILACQUA, M. P. & R. M. NELSON. 1993. Selectins. J. Clin. Invest. 91: 379-387.
20. CYBULSKY, M. I. & M. A. GIMBRONE. 1991. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251: 788-791.
21. BERLIN, C., R. F. BARGATZE, U. H. VON ANDRIAN, M. C. SZABO, S. R. HASSLEN, R. D. NELSON, E. L. BERG, S. L. ERIANDSEN & E. C. BUTCHER. 1995. α4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80: 413-422.
22. ALON, R., P. D. KASSNER, M. WOLDEMAR CARR, E. B. FINGER, M. E. HEMLER & T. A. SPRINGER. 1995. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J. Cell Biol. 128: 1243-1253.
23. MASUMOTO, A. & M. E. HEMLER. 1993. Multiple activation states of VLA-4. Mechanistic differences between adhesion to CS1/fibronectin and to vascular cell adhesion molecule-1. J. Biol. Chem. 268: 228-234.
24. KUIJPERS, T. W., E. P. MUL, M. BLOM, N. L. KOVACH, F. C. GAETA, V. TOLLEFSON, M. J. ELICES & J. M. HARLAN. 1993. Freezing adhesion molecules in a state of high avidity binding blocks eosinophil migration. J. Exp. Med. 178: 279-284.
25. WARRINGA, R. A., H. J. J. MENGELERS, P. H. M. KUIJPER, J. A. M. RAAIJMAKERS, P. L. BRUIJNZEEL & L. KOENDERMAN. 1991. In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals. Blood 79: 1836-1841.
26. LOPEZ, A. F., C. J. SANDERSON, J. R. GAMBLE, H. D. CAMBELL, I. G. YOUNG & M. A. VADAS. 1988. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 167: 219-224.
27. COEFFEIR, E., D. JOSEPH & B. B. VARGAFTIG. 1994. Role of interleukin-5 in enhanced migration of eosinophils from airways of immunized guinea-pigs. Br. J. Pharmacol. 11: 749-756.
28. WARDLAW, A. J., R. MOQBEL, O. CROMWELL & A. B. KAY. 1986. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J. Clin. Invest. 78: 1701-1706.
29. ALAM, R., S. STAFFORD, P. FORSYTHE, D. HARRISON, D. FAUBION, M. LETT-BROWN & J. GRANT. 1993. RANTES is a chemotactic and activating factor for human eosinophils. J. Immunol. 150: 3442-3448.
30. ROTHENBERG, M. E., W. F. OWEN, JR., D. S. SILBERSTINE, R. J. SOBERMAN, K. F. AUSTEN & R. L. STEVENS. 1987. Eosinophils cocultured with endothelial cells have increased survival and functional properties. Science 237: 645-647.
31. ROTHENBERG, M. E., W. F. OWEN, JR., D. S. SILBERSTINE, J. WOODS, R. J. SOBERMAN, K. F. AUSTEN & R. L. STEVENS. 1988. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J. Clin. Invest. 81: 1986-1992.
32. OWEN, W. F., JR., M. E. ROTHENBERG, D. S. SILBERSTINE, J. C. GASSON, R. L. STEVENS & K. F. AUSTEN. 1987. Regulation of human eosinophil viability, density, and function by granulocyte-macrophage colony stimulating factor in the presence of 3T3 fibroblasts. J. Exp. Med. 166: 129-141.
33. FUJISAWA, T., R. ABU-GHAZALEH, H. KITA, C. J. SANDERSON & G. J. GLEICH. 1990. Regulatory effects of cytokines on eosinophil degranulation. J. Immunol. 144: 642-646.
34. TOMIOKA, K., D. W. MACGLASHAN, JR., L. M. LICHTENSTEIN, B. S. BOCHNER & R. P. SCHLEIMER. 1993. GM-CSF regulates human eosinophil responses to F-Met peptide and platelet activating factor. J. Immunol. 151: 4989-4997.
35. SEHMI, R., A. J. WARDLAW, O. CROMWELL, K. KURIHARA, P. WALTMANN & A. B. KAY. 1992. Interleukin-5 selectivity enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood 79: 2952-2959.
36. SMITH, J. B., R. D. KUNJUMMEN & B. H. RAGHAVENDER. 1991. Eosinophils and neutrophils form human neonates have similar impairments of quantitative upregulation of Mac-1 (CD11b/CD18) expression in vitro. Pediatr. Res. 30: 355-361.
37. SMITH, J. B., R. D. KUNJUMMEN, T. K. KISHIMOTO & D. C. ANDERSON. 1992. Expression and regulation of L-selectin on eosinophils from human adults and neonates. Pediatr. Res. 32: 465-471.
38. SRIRAMARAO, P. & D. H. BROIDE. 1995. GM-CSF differentially modulates receptor expression and rolling of human eosinophils and neutrophils under conditions of flow in vivo. Am. J. Respir. Crit. Care Med. 151: A216.
39. SRIRAMARAO, P., E. BERGER, J. D. CHAMBERS, K.-E., ARFORS & K. R. GEHLSEN. 1993. High mannose type N-linked oligosaccharides on endothelial cells may influence β2 integrin mediated neutrophil adherence in vitro. J. Cell. Biochem. 51: 360-368.
40. YONG, K. L., P. M. ROWLES, K. G. PATTERSON & D. C. LINCH. 1992. Granulocyte-macrophage colony-stimulating factor induces neutrophil adhesion to pulmonary vascular endothelium in vivo. Role of β2 integrins. Blood 80: 1565-1575.
41. DEVEREUX, S., D. C. LINCH, D. CAMPOS COSTA, M. F. SPITTLE & A. M. JELLIFFE. 1987. Transient leucopenia induced by granulocyte-macrophage colony stimulating factor. Lancet 2: 1523-1524.
42. DEVEREUX, S., H. A. BULL, D. CAMPOS-COSTA, R. SAIB & D. C. LINCH. 1989. Granulocyte macrophage colony stimulating factor induced changes in cellular adhesion molecule expression and adhesion to endothelium: In-vitro and in-vivo studies in man. Br. J. Haematol. 71: 323-330.
43. POBER, J. S. & R. S. COTRAN. 1990. Cytokines and endothelial cell biology. Physiol. Rev. 70: 427-451.
44. HENOCQ, E. & B. B. VARGAFTIG. 1988. Skin eosinophilia in atopic patients. J. Allergy Clin. Immunol. 81: 691-695.
45. VENGE, P., L. HAKANSSON & C. G. B. PETERSON. 1987. Eosinophil activation in allergic disease. Int. Arch. Allergy Appl. Immunol. 82: 333-337.
46. WALKER, C., J. C. VIRCHOW, JR., P. L. BRUIJNZEEL & K. BLASER. 1991. T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J. Immunol. 146: 1829-1835.
47. BROIDE, D. H. & G. FIRESTEIN. 1992. Endobronchial allergen challenge in asthma: Demonstration of cellular source of granulocyte-macrophage colony stimulating factor by in situ hybridization. J. Clin. Invest. 88: 1048-1053.
48. SEDGWICK, J. B., W. J. CALHOUN, G. J. GLEICH, K. KITA, J. S. ABRAMS, L. B. SCHWARTZ, B. VOLOVITZ, M. BEN-YAAKOV & W. W. BUSSE. 1991. Immediate and late airway response of allergic rhinitis patients to segmental challenge. Characterization of eosinophil and mast cell mediators. Am. Rev. Respir. Dis. 144: 1274-1281.
49. MASSEY, W., B. FRIEDMAN, M. KATO, P. COOPER, A. KAGEY-SOBOTKA, L. M. LICHTENSTEIN & R. P. SCHLEIMER. 1993. Appearance of granulocyte-macrophage colony-stimulating factor activity at allergen-challenged cutaneous late-phase reaction sites. J. Immunol. 150: 1084-1092.